Nemtabrutinib
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Nemtabrutinib, covering 2024-09-19 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]